# Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

> **NCT00222131** · PHASE2 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 73 (actual)

## Conditions studied

- Indigestion

## Interventions

- **DRUG:** Esomeprazole
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00222131
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222131, "Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00222131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*